In this issue of The Journal of Rheumatology, Nagase et al assessed the 2-year effectiveness and safety of tocilizumab (TCZ) in treating Japanese patients with giant cell arteritis (GCA) in real-world settings.1 TCZ targets interleukin 6 (IL-6), a key cytokine involved in the inflammatory processes of GCA. Both open-label studies reflecting daily clinical practice2,3 and controlled trials4,5 have shown the effectiveness of TCZ in managing GCA in patients from Western countries.

Miguel Ángel González-Gay

Santos Castañeda

Iván Ferraz-Amaro

The Journal of Rheumatology

《风湿病学杂志》是由 EARL D. SILVERMAN 编辑的国际月刊。该杂志收录了来自风湿病学和相关领域的科学家关于临床主题的研究文章，以及会议记录作为常规问题的补充。我们为风湿病学服务 41 年的亮点包括：开创性和挑衅性的社论，例如“倒金字塔”、著名的儿科风湿病学、OMERACT 和加拿大风湿病学协会的会议记录、COCHRANE 肌肉骨骼评论以及新兴疗法的补充。

The Journal of Rheumatology is an international monthly journal edited by EARL D. SILVERMAN. It publishes research articles on clinical topics from scientists in rheumatology and related fields, along with regular supplements of conference proceedings. Highlights of our 41 years of service to rheumatology include groundbreaking and thought-provoking editorials, such as 'The Inverted Pyramid', notable pediatric rheumatology, OMERACT and Canadian Rheumatology Association conference proceedings, COCHRANE musculoskeletal reviews, and supplements on emerging therapies.

《风湿病学杂志》是由EARL D. SILVERMAN编辑的国际月刊。该杂志发表来自风湿病学及相关领域的科学家们关于临床主题的研究文章，并定期补充会议记录。我们为风湿病学服务41年的亮点包括：开创性和引人深思的社论，如“倒金字塔”、著名的儿科风湿病学、OMERACT和加拿大风湿病学协会的会议记录、COCHRANE肌肉骨骼评论以及新兴疗法的补充。

Category	Quartile
医学	2
医学, 风湿病学	3

Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info